Post-myocardial infarct p27 fusion protein intravenous delivery averts adverse remodelling and improves heart function and survival in rodents

Cardiovascular Research

Volumn 94, Issue 3, 2012, Pages 492-500

  Konecny, Filip ^a,b   Zou, Jian ^a,b   Husain, Mansoor ^a,b   Von Harsdorf, Rdiger ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; Cell cycle inhibitor; Hyperthrophy; Myocardial infarct; TAT fusion protein p27

Indexed keywords

HYBRID PROTEIN; PROTEIN P27; RECOMBINANT PROTEIN; TRANSACTIVATOR OF TRANSCRIPTION P27 FUSION PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEART VOLUME; HISTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; SCAR; SURVIVAL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FIBROSIS; HEART; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, INBRED F344; VENTRICULAR REMODELING;

EID: 84861355524     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs138     Document Type: Article

References (17)

1. Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 2010;122:2727-2735.
2. Hauck L, Harms C, An J, Rohne J, Gertz K, Dietz R et al. Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med 2008;14:315-324. (Pubitemid 351347917)
3. Hauck L, Hansmann G, Dietz R, von Harsdorf R. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ Res 2002;91:782-789. (Pubitemid 35285075)
4. Burton PB, Yacoub MH, Barton PJ. Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J 1999;20: 604-611. (Pubitemid 29176683)
5. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998;4:1449-1452. (Pubitemid 28553472)
6. Zaidi SH, Huang Q, Momen A, Riazi A, Husain M. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J Am Coll Cardiol 2010;55: 135-143.
7. Hoefer J, Azam MA, Kroetsch JT, Leong-Poi H, Momen MA, Voigtlaender-Bolz J et al. Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. Circ Res 2010;107:923-933.
8. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008;9:1422-1434.
9. Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 2000;279:422-428.
10. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997;100: 1991-1999. (Pubitemid 27459352)
11. Gustafsson AB, Sayen MR, Williams SD, Crow MT, Gottlieb RA. TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective. Circulation 2002;106:735-739. (Pubitemid 34851935)
12. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007;14:146-157. (Pubitemid 44911902)
13. Tsoporis JN, Marks A, Haddad A, Dawood F, Liu PP, Parker TG. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 2005;111:598-606. (Pubitemid 40216487)
14. Lymperopoulos A, Rengo G, Zincarelli C, Kim J, Koch WJ. Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. J Am Coll Cardiol 2011;57:356-365.
15. Poolman RA, Li JM, Durand B, Brooks G. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res 1999;85:117-127. (Pubitemid 29343310)
16. Liao HS, Kang PM, Nagashima H, Yamasaki N, Usheva A, Ding B et al. Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ Res 2001;88:443-450. (Pubitemid 32200119)
17. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM et al. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 2006;114 (1 Suppl): I206-I213. (Pubitemid 44297152)